Left ventricular function is not impaired in weight-lifters who use anabolic steroids

Miriam Hospital, Providence, Rhode Island 02906.

Recent reports suggest that anabolic steroid use might deleteriously affect left ventricular function. To examine this possibility, the present study measured left ventricular size and function with use of Doppler echocardiographic techniques in 23 weight lifters: 12 who were currently using anabolic steroids and 11 who reported that they had never used these drugs. Drug users had administered anabolic steroids to themselves for at least three cycles over the past year. All studies were interpreted by blind review and group assignment was confirmed by urine testing. Average age, years of exercise training and body weight, as well as heart rate and blood pressure at rest were similar in both groups. Cardiac dimensions (mean +/- SD) including left ventricular diastolic cavity diameter (57 +/- 3 vs. 56 +/- 5 mm), septal thickness (10 +/- 2 vs. 9 +/- 1 mm), posterior wall thickness (8 +/- 1 vs. 8 +/- 1 mm) and myocardial mass (149 +/- 27 vs. 135 +/- 21 g) did not differ between the anabolic steroid users and nonusers, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. W. Parker and P. D. Thompson Anabolic-Androgenic Steroids: Worse for the Heart Than We Knew? Circ Heart Fail, July 1, 2010; 3(4): 470 - 471. [Full Text] [PDF]

				A. L. Baggish, R. B. Weiner, G. Kanayama, J. I. Hudson, M. H. Picard, A. M. Hutter Jr, and H. G. Pope Jr Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction Circ Heart Fail, July 1, 2010; 3(4): 472 - 476. [Abstract] [Full Text] [PDF]

				A. D'Andrea, P. Caso, G. Salerno, R. Scarafile, G. De Corato, C. Mita, G. Di Salvo, S. Severino, S. Cuomo, B. Liccardo, et al. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis * COMMENTARY Br. J. Sports Med., March 1, 2007; 41(3): 149 - 155. [Abstract] [Full Text] [PDF]

				A Urhausen, T Albers, and W Kindermann Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, May 1, 2004; 90(5): 496 - 501. [Abstract] [Full Text] [PDF]

				W. B. Abernethy III, J. K. Choo, and A. M. Hutter Jr Reply J. Am. Coll. Cardiol., August 6, 2003; 42(3): 588 - 589. [Full Text] [PDF]

				M. A. Sader, K. A. Griffiths, R. J. McCredie, D. J. Handelsman, and D. S. Celermajer Androgenic anabolic steroids and arterial structure and function in male bodybuilders J. Am. Coll. Cardiol., January 1, 2001; 37(1): 224 - 230. [Abstract] [Full Text] [PDF]

				B. M. Pluim, A. H. Zwinderman, A. van der Laarse, and E. E. van der Wall The Athlete s Heart : A Meta-Analysis of Cardiac Structure and Function Circulation, January 25, 2000; 101(3): 336 - 344. [Abstract] [Full Text] [PDF]

				A. Pelliccia and B. J. Maron Physiologic Left Ventricular Cavity Dilatation in Elite Athletes Ann Intern Med, October 5, 1999; 131(7): 546 - 546. [Full Text] [PDF]

				J. D. Marsh, M. H. Lehmann, R. H. Ritchie, J. K. Gwathmey, G. E. Green, and R. J. Schiebinger Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes Circulation, July 21, 1998; 98(3): 256 - 261. [Abstract] [Full Text] [PDF]